Article
High daily dose Short COurse PrimaquinE after G6PD testing for the radical cure of<i>Plasmodium vivax</i>malaria in Indonesia and Papua New Guinea: The SCOPE implementation study protocol
2024-12-16
Abstract excerpt
<h4>Introduction</h4> Plasmodium vivax malaria remains an important threat to the public in the Asia Pacific region. Preventing P. vivax relapses is crucial for reducing morbidity from malaria and ultimately controlling and eliminating this species. Primaquine is the only widely available drug with antirelapse activity against dormant stages of P. vivax. Its widespread use in clinical practice is limited by its po...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c9b000da-63ea-5a4f-bd0d-f6c80dc3c02b
- DOI
- 10.1101/2024.12.15.24318165
